Hair Loss Treatments

/Hair Loss Treatments

Invasive Breast Cancer

Breast cancer is a type of cancer that begins in the tissue of the breast. There are two main types of breast cancer, including ductal carcinoma and lobular carcinoma. The majority of breast cancer is ductal carcinoma. Sometimes breast cancer can begin in other regions of the breast, but primarily it begins in the ducts or the lobules. Invasive breast cancer means that the cancer has spread from the milk duct or lobule to other breast tissue. Non-invasive breast cancer means that cancer is called “in situ” and has not yet spread. Read below to learn about symptoms of invasive breast cancer. Symptoms Early stage breast cancer usually does not have any symptoms. For this very reason it is very important for you to complete regular breast examinations, which might facilitate the discovery of breast cancer earlier than if you fail to do breast examinations. As breast cancer grows and advances in stages, there might be a breast lump in your breast or armpit that is hard, with uneven edges, which does not hurt. Your breast or nipple might change color, size, shape, or feel. Your breast may excrete fluid, such as blood or pus. Bone pain, breast pain, skin ulcers, swelling of one arm, and weight loss are also indications that breast cancer may be present. Treatment If you have been diagnosed with breast cancer there are numerous treatments that are available to you. However, treatment is dependent on the type and stage of cancer, whether the cancer is sensitive to certain hormones, and whether the cancer overproduces HER2/neu, a particular gene. Cancer treatment may include chemotherapy, radiation therapy, hormonal therapy, and/or targeted therapy. The type of treatment that is most appropriate will be [...]

By |

Three Men’s Hair Styles for Fall 2014

Fall is upon us, and with the change of seasons comes a change of styles. Yes, green leaves are turning orange, hot summer days are cooling into enjoyable autumn ones, and short-sleeved shirts are being covered by sweaters. Why not go with the flow of the shifting seasons and their sweeping transformations this year and opt for a new do to usher in the autumn months? Today we highlight three trendy men’s styles to consider for this coming fall. If you are struggling with hair thinning or loss and are seeking a way to keep your look current, schedule a free consultation with one of our specialists today. Go for Lift The pompadour has been popular all year (and worldwide, as we noted during this summer’s Cup), and the style is still going strong as we swing into fall. Consider an undercut of any variety, which allows for whatever combination of lift and length you prefer. This prohibition cut featured on Behind the Chair is a slick look for the working man while the looser version shown on Men’s Hair Style Trends can be perfect for a relaxed evening. Already rocking an undercut? Try pairing it with a beard as the months get cooler. A Caesar with Bangs If a typical Caesar is your go to style, make the jump from average to awesome this autumn by simply allowing a bit more length in front. This small shift can make a man look stylish without much styling, and your hairdresser can work the change in over time by allowing for more drama every time you come in for your next cut. Perhaps you will decide you are happy with just a little bit of additional [...]

By |

Hair Loss In Women

It is a widely accepted misconception that hair thinning and balding are problems that are unique to the male gender. Though still not desirable, there is an expectation of sorts that hair loss comes with age for men, but not for women. In actuality, hair loss does not discriminate and a notably high percentage of women will experience some degree of thinning or balding during the course of their lifetime. The single largest cause of hair loss in women has hereditary origins and is known as Female Pattern Hair Loss (FPHL). This type of loss is usually identified by thinning along the part rather than the thinning at the hairline that is frequent in its male counterpart, Male Pattern Hair Loss. The degree of a woman’s hair loss with FPHL is measured using the Savin Scale. According to a 2013 study conducted by the Department of Dermatology and Cutaneous Surgery at the University of Miami, some 21 million women in the United States alone are suffering from FPHL with 12% of women seeing signs by the time they are 30 and upwards of 30-40% of women dealing with FPHL in their 60s. These numbers are astounding when one considers how little female hair loss is discussed and acknowledged in today’s society! In addition to FPHL, hair loss in women can also be attributed to a number of other causes including hormonal changes such as postpartum, birth control, or menopausal hair loss, extreme stress, regular overstyling, medications including, but not limited to, chemotherapy, underlying medical conditions such as hyperthyroidism or lupus, other known hair loss conditions, such as alopecia areata and trichotillomania, and the list goes on and on. It can seem a bit daunting to [...]

By |

Another Alopecia Areata Drug Breakthrough

(source: http://newsroom.cumc.columbia.edu/blog/2014/08/17/fda-approved-drug-restores-hair-patients-alopecia-areata/) Right on the heels of June’s alopecia universalis breakthrough comes a second publication announcing good news for those suffering from the spectrum of alopecia areata diseases. An August article in Nature Medicine from a team out of New York’s Columbia University presents the successful use of the drug ruxolitinib for treatment of alopecia areata in three patients with varying degrees of hair loss. Ruxolitinib is a JAK inhibitor approved by the FDA for use in treating a bone marrow cancer called myelofibrosis. It, along with tofacitinib citrate (which we featured here after it made big news in June), was identified by the Columbia University team as having potential applications in alopecia areata due its ability to block certain immune pathways that have been found to be responsible for the autoimmune attacks on hair follicles. The progress was undeniable as the result of two 20mg doses per day for five months was ‘complete restoration’ in all three initial trials. Additionally, the expectation is that this medication will re-establish a full mane during treatment and can then be discontinued, essentially providing a cure rather than an indefinite drug regimen. These results inspire huge amounts of hope! Researchers are quick to point out the need for further investigation as these newly opened doors prompt questions regarding the continued consistency of results, short and long term side effects, and the comparisons between the two drugs being actively tested. Despite the numerous directions for future research though, the results published in this latest study have enormous implications for what Dr. Angela Christiano, a co-lead study author from Columbia University, describes as “a tremendously large and motivated population of patients who have no other treatments available.” You [...]

By |